Skip to content
TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
-$61.04M-3.5%-$59M-17.7%-$50.11M-1.9%-$49.18M+7.2%-$52.99M+4.9%
$9.06M-14.7%$10.62M+5.7%$10.05M+6.6%$9.43M+5.1%$8.97M+6.6%
$33.16M-1.9%$33.82M-2.9%$34.82M+0.3%$34.73M+8.9%$31.89M+4.2%
-$12.93M+19.0%-$15.97M-31.4%-$12.15M+18.5%-$14.9M+42.1%-$25.75M+30.7%
$13.04M-3.6%$13.52M-4.8%$14.19M-0.4%$14.25M+27.1%$11.21M-3.3%
$7.33M-44.7%$13.25M+89.1%$7.01M+73.7%$4.03M-86.4%$29.72M-16.0%
$1.78M-14.7%$2.09M+185%$731K-1.1%$739K+1,073%$63K-60.6%
-$4.42M+56.3%-$10.13M-351%$4.04M+347%
-$25.96M+11.9%-$29.49M-11.9%-$26.34M+9.6%-$29.15M+21.1%-$36.96M+24.2%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Treace Medical Concepts, Inc. generate?
Treace Medical Concepts, Inc. (TMCI) generated -$12.9M in operating cash flow over the trailing twelve months.
What is Treace Medical Concepts, Inc.'s free cash flow?
After $13.0M of capital expenditures, Treace Medical Concepts, Inc.'s free cash flow was -$26.0M over the trailing twelve months, up 29.8% year over year.
Where does Treace Medical Concepts, Inc.'s cash flow data come from?
Every line is extracted from Treace Medical Concepts, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.